Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Conditions:   Clear Cell Renal Cell Carcinoma Metastatic;   TNBC - Triple-Negative Breast Cancer;   Head and Neck Cancer;   Non-small-cell Lung Carcinoma;   Mesothelioma, Malignant Intervention:   Drug: CA9hu-1 Sponsor:   Mabpro, a.s. Not yet recruiting

Source: ClinicalTrials.gov - January 26, 2023 Category: Research Source Type: clinical trials